author_facet Ishii, Toshihiko
Ishii, Toshihiko
author Ishii, Toshihiko
spellingShingle Ishii, Toshihiko
Folia Pharmacologica Japonica
Development of an anti-CCR4 antibody, mogamulizumab, the first approved antibody made by POTELLIGENT^|^#174; technology
Pharmacology
author_sort ishii, toshihiko
spelling Ishii, Toshihiko 0015-5691 1347-8397 Japanese Pharmacological Society Pharmacology http://dx.doi.org/10.1254/fpj.142.167 Development of an anti-CCR4 antibody, mogamulizumab, the first approved antibody made by POTELLIGENT^|^#174; technology Folia Pharmacologica Japonica
doi_str_mv 10.1254/fpj.142.167
facet_avail Online
Free
finc_class_facet Chemie und Pharmazie
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTI1NC9mcGouMTQyLjE2Nw
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTI1NC9mcGouMTQyLjE2Nw
institution DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-D161
DE-Zwi2
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
imprint Japanese Pharmacological Society, 2013
imprint_str_mv Japanese Pharmacological Society, 2013
issn 0015-5691
1347-8397
issn_str_mv 0015-5691
1347-8397
language English
mega_collection Japanese Pharmacological Society (CrossRef)
match_str ishii2013developmentofananticcr4antibodymogamulizumabthefirstapprovedantibodymadebypotelligent174technology
publishDateSort 2013
publisher Japanese Pharmacological Society
recordtype ai
record_format ai
series Folia Pharmacologica Japonica
source_id 49
title Development of an anti-CCR4 antibody, mogamulizumab, the first approved antibody made by POTELLIGENT^|^#174; technology
title_unstemmed Development of an anti-CCR4 antibody, mogamulizumab, the first approved antibody made by POTELLIGENT^|^#174; technology
title_full Development of an anti-CCR4 antibody, mogamulizumab, the first approved antibody made by POTELLIGENT^|^#174; technology
title_fullStr Development of an anti-CCR4 antibody, mogamulizumab, the first approved antibody made by POTELLIGENT^|^#174; technology
title_full_unstemmed Development of an anti-CCR4 antibody, mogamulizumab, the first approved antibody made by POTELLIGENT^|^#174; technology
title_short Development of an anti-CCR4 antibody, mogamulizumab, the first approved antibody made by POTELLIGENT^|^#174; technology
title_sort development of an anti-ccr4 antibody, mogamulizumab, the first approved antibody made by potelligent^|^#174; technology
topic Pharmacology
url http://dx.doi.org/10.1254/fpj.142.167
publishDate 2013
physical 167-171
description
container_issue 4
container_start_page 167
container_title Folia Pharmacologica Japonica
container_volume 142
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792331145807921161
geogr_code not assigned
last_indexed 2024-03-01T13:36:17.905Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Development+of+an+anti-CCR4+antibody%2C+mogamulizumab%2C+the+first+approved+antibody+made+by+POTELLIGENT%5E%7C%5E%23174%3B+technology&rft.date=2013-01-01&genre=article&issn=1347-8397&volume=142&issue=4&spage=167&epage=171&pages=167-171&jtitle=Folia+Pharmacologica+Japonica&atitle=Development+of+an+anti-CCR4+antibody%2C+mogamulizumab%2C+the+first+approved+antibody+made+by+POTELLIGENT%5E%7C%5E%23174%3B+technology&aulast=Ishii&aufirst=Toshihiko&rft_id=info%3Adoi%2F10.1254%2Ffpj.142.167&rft.language%5B0%5D=eng
SOLR
_version_ 1792331145807921161
author Ishii, Toshihiko
author_facet Ishii, Toshihiko, Ishii, Toshihiko
author_sort ishii, toshihiko
container_issue 4
container_start_page 167
container_title Folia Pharmacologica Japonica
container_volume 142
description
doi_str_mv 10.1254/fpj.142.167
facet_avail Online, Free
finc_class_facet Chemie und Pharmazie
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTI1NC9mcGouMTQyLjE2Nw
imprint Japanese Pharmacological Society, 2013
imprint_str_mv Japanese Pharmacological Society, 2013
institution DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-D161, DE-Zwi2, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14
issn 0015-5691, 1347-8397
issn_str_mv 0015-5691, 1347-8397
language English
last_indexed 2024-03-01T13:36:17.905Z
match_str ishii2013developmentofananticcr4antibodymogamulizumabthefirstapprovedantibodymadebypotelligent174technology
mega_collection Japanese Pharmacological Society (CrossRef)
physical 167-171
publishDate 2013
publishDateSort 2013
publisher Japanese Pharmacological Society
record_format ai
recordtype ai
series Folia Pharmacologica Japonica
source_id 49
spelling Ishii, Toshihiko 0015-5691 1347-8397 Japanese Pharmacological Society Pharmacology http://dx.doi.org/10.1254/fpj.142.167 Development of an anti-CCR4 antibody, mogamulizumab, the first approved antibody made by POTELLIGENT^|^#174; technology Folia Pharmacologica Japonica
spellingShingle Ishii, Toshihiko, Folia Pharmacologica Japonica, Development of an anti-CCR4 antibody, mogamulizumab, the first approved antibody made by POTELLIGENT^|^#174; technology, Pharmacology
title Development of an anti-CCR4 antibody, mogamulizumab, the first approved antibody made by POTELLIGENT^|^#174; technology
title_full Development of an anti-CCR4 antibody, mogamulizumab, the first approved antibody made by POTELLIGENT^|^#174; technology
title_fullStr Development of an anti-CCR4 antibody, mogamulizumab, the first approved antibody made by POTELLIGENT^|^#174; technology
title_full_unstemmed Development of an anti-CCR4 antibody, mogamulizumab, the first approved antibody made by POTELLIGENT^|^#174; technology
title_short Development of an anti-CCR4 antibody, mogamulizumab, the first approved antibody made by POTELLIGENT^|^#174; technology
title_sort development of an anti-ccr4 antibody, mogamulizumab, the first approved antibody made by potelligent^|^#174; technology
title_unstemmed Development of an anti-CCR4 antibody, mogamulizumab, the first approved antibody made by POTELLIGENT^|^#174; technology
topic Pharmacology
url http://dx.doi.org/10.1254/fpj.142.167